Longevity Health enters purchase agreement for up to $625,000 in convertible notes

Longevity Health Holdings, Inc.

Initial $375,000 gross proceeds drawn via 10% senior secured convertible note due Feb 29, 2028, principal $416,667.
Note convertible at $0.50/share, secured by substantially all assets; 10% original issue discount applies.
Up to $250,000 additional gross proceeds from two potential notes ($138,889 principal each); second tranche subject to resale registration, third at Puritan's discretion.
Agreement dated Aug 31, 2026 with Puritan Partners LLC; company cites regenerative bio-aesthetics platform buildout.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.